CDEK
← All organizations

Lantheus Medical Imaging

For profitContributed to NMEWebsite ↗

Also known as: LANTHEUS MEDCL | LANTHEUS MEDICAL | Lantheus Medical Imaging | Medical Monitor - Lantheus Medical Imaging

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Dec 1, 2003

First marketed drug

Oct 10, 1974

First NDA

Oct 10, 1974

Last known activity

Oct 31, 2025

Timeline

1950s

  1. Jun 1, 1956

    Lantheus Medical Imaging— Founded

1970s

  1. Dec 16, 1977

    thallous chloride ti 201— NDA Organization

  2. Dec 16, 1977

    thallous chloride ti 201— NDA Secondary Org

2010s

  1. Feb 4, 2014

    fludeoxyglucose f-18— Marketing Organization

  2. Oct 2, 2019

    Progenics— Acquired

Drugs by trial phase (38 distinct, 110 trials)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (11)

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (50)

Details

Founded
North Billerica, MA, US Jun 1, 1956
First NDA
Oct 10, 1974
Last known activity
Oct 31, 2025

Designations held

  • Priority review